Phosphodiesterase 2 inhibition preferentially promotes NO/guanylyl cyclase/cGMP signaling to reverse the development of heart failure
about
Phosphodiesterase 2 inhibition preferentially promotes NO/guanylyl cyclase/cGMP signaling to reverse the development of heart failure
description
scientific article published on 16 July 2018
@en
name
Phosphodiesterase 2 inhibition ...... e development of heart failure
@en
type
label
Phosphodiesterase 2 inhibition ...... e development of heart failure
@en
prefLabel
Phosphodiesterase 2 inhibition ...... e development of heart failure
@en
P2093
P356
P1476
Phosphodiesterase 2 inhibition ...... e development of heart failure
@en
P2093
Amie J Moyes
Kristen J Bubb
Matthew S Dukinfield
Michael A Tones
Michael E J Preedy
Reshma S Baliga
Sandy M Chu
P304
E7428-E7437
P356
10.1073/PNAS.1800996115
P577
2018-07-16T00:00:00Z